Chemoinformaics analysis of BETA-CARBOLINE-1-PROPIONIC-ACID
| Molecular Weight | 240.262 | nRot | 3 |
| Heavy Atom Molecular Weight | 228.166 | nRig | 16 |
| Exact Molecular Weight | 240.09 | nRing | 3 |
| Solubility: LogS | -3.501 | nHRing | 2 |
| Solubility: LogP | 1.983 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 15 |
| nHA | 2 | APOL | 35.1855 |
| nHD | 2 | BPOL | 14.6165 |
| QED | 0.739 |
| Synth | 2.17 |
| Natural Product Likeliness | 0.518 |
| NR-PPAR-gamma | 0.954 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.002 |
| HIA | 0.016 |
| CACO-2 | -4.773 |
| MDCK | 0.0000144 |
| BBB | 0.13 |
| PPB | 0.864466 |
| VDSS | 0.431 |
| FU | 0.0663788 |
| CYP1A2-inh | 0.407 |
| CYP1A2-sub | 0.675 |
| CYP2c19-inh | 0.053 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.026 |
| CYP2c9-sub | 0.901 |
| CYP2d6-inh | 0.038 |
| CYP2d6-sub | 0.72 |
| CYP3a4-inh | 0.025 |
| CYP3a4-sub | 0.103 |
| CL | 2.016 |
| T12 | 0.856 |
| hERG | 0.032 |
| Ames | 0.038 |
| ROA | 0.753 |
| SkinSen | 0.332 |
| Carcinogencity | 0.239 |
| EI | 0.66 |
| Respiratory | 0.983 |
| NR-Aromatase | 0.019 |
| Antiviral | Yes |
| Prediction | 0.715872 |